Pharming (PHAR) Shares Outstanding (Weighted Average) (2019 - 2025)
Pharming's Shares Outstanding (Weighted Average) history spans 7 years, with the latest figure at $8.0 million for Q4 2025.
- Quarterly results put Shares Outstanding (Weighted Average) at $8.0 million for Q4 2025, up 3.09% from a year ago — trailing twelve months through Dec 2025 was $8.0 million (up 3.09% YoY), and the annual figure for FY2025 was $8.0 million, up 3.09%.
- Shares Outstanding (Weighted Average) for Q4 2025 was $8.0 million at Pharming, up from $7.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $671.1 million in Q4 2023 to a low of $7.8 million in Q4 2024.
- The 5-year median for Shares Outstanding (Weighted Average) is $642.0 million (2021), against an average of $395.5 million.
- The sharpest move saw Shares Outstanding (Weighted Average) rose 3.45% in 2023, then crashed 98.84% in 2024.
- Year by year, Shares Outstanding (Weighted Average) stood at $642.0 million in 2021, then grew by 1.04% to $648.7 million in 2022, then grew by 3.45% to $671.1 million in 2023, then crashed by 98.84% to $7.8 million in 2024, then increased by 3.09% to $8.0 million in 2025.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $8.0 million, $7.8 million, and $671.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.